Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
103.48
-0.85 (-0.81%)
At close: Jul 15, 2025, 4:00 PM
105.04
+1.56 (1.51%)
After-hours: Jul 15, 2025, 7:40 PM EDT
Boston Scientific Employees
Boston Scientific had 53,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.42% compared to the previous year.
Employees
53,000
Change (1Y)
5,000
Growth (1Y)
10.42%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
153.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 53,000 | 5,000 | 10.42% |
Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
Dec 31, 2019 | 36,000 | 4,000 | 12.50% |
Dec 31, 2018 | 32,000 | 3,000 | 10.34% |
Dec 31, 2017 | 29,000 | 2,000 | 7.41% |
Dec 31, 2016 | 27,000 | 2,000 | 8.00% |
Dec 31, 2015 | 25,000 | 1,000 | 4.17% |
Dec 31, 2014 | 24,000 | 1,000 | 4.35% |
Dec 31, 2013 | 23,000 | -1,000 | -4.17% |
Dec 31, 2012 | 24,000 | 0 | - |
Dec 31, 2011 | 24,000 | -1,000 | -4.00% |
Dec 31, 2010 | 25,000 | -1,000 | -3.85% |
Dec 31, 2009 | 26,000 | 1,200 | 4.84% |
Dec 31, 2008 | 24,800 | -2,700 | -9.82% |
Dec 31, 2007 | 27,500 | -1,100 | -3.85% |
Dec 31, 2006 | 28,600 | 8,800 | 44.44% |
Dec 31, 2005 | 19,800 | 2,300 | 13.14% |
Dec 31, 2004 | 17,500 | 2,500 | 16.67% |
Dec 31, 2003 | 15,000 | 1,100 | 7.91% |
Dec 31, 2002 | 13,900 | -500 | -3.47% |
Dec 31, 2001 | 14,400 | 680 | 4.96% |
Dec 31, 2000 | 13,720 | 1,105 | 8.76% |
Dec 31, 1999 | 12,615 | -1,385 | -9.89% |
Dec 31, 1998 | 14,000 | 3,000 | 27.27% |
Dec 31, 1997 | 11,000 | 1,420 | 14.82% |
Dec 31, 1996 | 9,580 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BSX News
- 4 days ago - North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf - GlobeNewsWire
- 8 days ago - Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System - PRNewsWire
- 14 days ago - Boston Scientific announces conference call discussing second quarter 2025 results - PRNewsWire
- 4 weeks ago - I'm Buying Dividend Aristocrats At Bargain Basement Prices - Seeking Alpha
- 4 weeks ago - What's Happening With Boston Scientific Stock? - Forbes
- 5 weeks ago - 20 stocks bucking bad trends on Wall Street — what might be next for them? - Market Watch
- 5 weeks ago - 3 Growth Stocks That Aren't the Magnificent 7 - Barrons
- 6 weeks ago - Boston Scientific: Old, Reliable; Buy For Their Consistent Growth - Seeking Alpha